Company Information

Company Zuellig Pharma Holdings Pte. Limited
www.zuelligpharma.com
Type:
Company
Country:
Singapore
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Privately Held
Global Compact Status:
Active
Participant Since
30 October 2019
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2025

Communication On Progress

Published On Title Level/Status
26-Jul-2024 2024 Communication on Progress Submitted
28-Dec-2023 2023 Communication on Progress Submitted
12-Apr-2022 2021 GRI Sustainability Report Active
22-Feb-2022 Grace Letter Not applicable
28-Jan-2021 Zuellig Pharma Communication on Progress 2020 Active
03-Dec-2020 Reporting Cycle Adjustment Not applicable
11-Dec-2019 Zuellig Pharma Communication on Progress Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.